FDA OKs second test to see if Essure contraceptive is placed right

The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal(Reuters) – Bayer Healthcare said on Wednesday the U.S. Food and Drug Administration approved using transvaginal ultrasound as an alternate test to confirm if the company's Essure permanent birth control device has been placed properly. Essure is a small metal coil inserted into woman's fallopian tubes. In a transvaginal ultrasound (TVU), sound waves emitted from a probe placed in vagina help a physician check if Essure has been placed properly.



Sexual Health News Headlines – Yahoo! News